Variables | Overall [N = 151 (%)] | Willing to participate in CTS Yes [n = 127(%)] No [n = 24(%)] | P-value | |
---|---|---|---|---|
DEMOGRAPHICS | ||||
Age; mean (st.dev) | 41.6 (11.9) | 41.2 (11.7) | 43.8 (13.1) | 0.322a |
Sex | 0.319 | |||
Male | 77 (51.0) | 67 (52.8) | 10 (41.7) | |
Female | 74 (49.0) | 60 (47.2) | 14 (58.3) | |
Marital status | 1.000 | |||
Married | 91 (60.3) | 76 (59.8) | 15 (62.5) | |
Separated | 33 (21.8) | 28 (22.1) | 5 (20.8) | |
Never married | 11 (7.3) | 9 (7.1) | 2 (8.3) | |
Widow/widower | 16 (10.6) | 14 (11.0) | 2 (8.3) | |
BENEFITS OF PARTICIPATING IN CTS | ||||
Improved health status | 0.0131 | |||
Yes | 144 (95.4) | 124 (97.6) | 20 (83.3) | |
No | 7 (4.6) | 3(2.4) | 4 (16.7) | |
Special status | < 0.001 | |||
Yes | 128 (87.7) | 113 (92.6) | 15 (62.5) | |
No | 18 (12.3) | 9 (7.4) | 9 (37.5) | |
Develop new treatment | 0.053 | |||
Yes | 129 (86.6) | 112 (88.9) | 17 (73.9) | |
No | 20 (13.4) | 14 (11.1) | 6 (26.1) | |
Future benefit | 0.228 | |||
Yes | 132 (90.4) | 114 (91.9) | 18 (81.8) | |
No | 14 (9.6) | 10 (8.1) | 4 (18.2) | |
Compensate participants | 1.0001 | |||
Yes | 133 (88.7) | 111 (88.1) | 22 (91.7) | |
No | 14 (9.3) | 12 (9.5) | 2 (8.3) | |
Don’t know | 3 (2.0) | 3 (2.4) | 0 | |
Fairly compensated | 0.002 | |||
Yes | 94 (65.2) | 86 (71.1) | 8 (34.8) | |
No | 25 (17.4) | 19 (15.7) | 6 (26.1) | |
Don’t know | 25 (17.4) | 16 (13.2) | 9 (39.1) | |
ULTIMATE BENEFICIARIES | ||||
Pharmaceutical companies | 0.935 | |||
Yes | 43 (28.5) | 36 (28.4) | 7 (29.2) | |
No | 108 (71.5) | 91 (71.6) | 17 (70.8) | |
Hospitals | < 0.001 | |||
Yes | 48 (31.8) | 33 (26.0) | 15 (62.5) | |
No | 103 (68.2) | 94 (74.0) | 9 (37.5) | |
Future patients | 0.081 | |||
Yes | 110 (72.9) | 96 (75.6) | 14 (58.3) | |
No | 41 (27.1) | 31 (24.4) | 10 (41.7) | |
Encourage CTs participation | < 0.0011 | |||
Yes | 136 (95.1) | 120 (100.0) | 16 (69.6) | |
No | 7 (4.9) | 0(0.0) | 7(30.4) | |
BARRIERS | ||||
Fear of CT drugs | 0.167 | |||
Yes | 34 (22.5) | 26 (20.5) | 8 (33.3) | |
No | 117 (77.5) | 101 (79.5) | 16 (66.7) | |
Blood loss | 0.2011 | |||
Yes | 20 (13.2) | 19 (15.0) | 1 (4.2) | |
No | 131 (86.8) | 108 (85.0) | 23 (95.8) | |
Pain | 0.1271 | |||
Yes | 24 (15.9) | 23 (18.1) | 1 (4.2) | |
No | 127 (84.1) | 104 (81.9) | 23 (95.8) | |
Treatment failure | 0.008 | |||
Yes | 19 (12.6) | 12 (9.5) | 7 (29.2) | |
No | 132 (87.4) | 115 (90.5) | 17 (70.8) | |
Death | 0.0361 | |||
Yes | 9 (6.0) | 5 (3.9) | 4 (16.7) | |
No | 142 (94.0) | 122 (96.1) | 20 (83.3) | |
INSTITUTIONAL FACTORS | ||||
Fair selection | 0.0821 | |||
Yes | 123 (86.0) | 106 (88.3) | 17 (73.9) | |
No | 15 (10.5) | 11 (9.2) | 4 (17.4) | |
I don’t know | 5 (3.5) | 3 (2.5) | 2 (8.7) | |
Year Joined IDI | 0.3871 | |||
2002–2005 | 61 (40.4) | 48 (37.8) | 13 (54.2) | |
2006–2010 | 39 (25.8) | 34 (26.8) | 5 (20.8) | |
2011–2016 | 51 (33.8) | 45 (35.4) | 6 (25.0) |